Literature DB >> 17317357

Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts.

William Joseph van Gaal1, Robin Patrick Choudhury, Italo Porto, Keith Channon, Adrian Banning, Vladimir Dzavik, Rachael Ramsamujh, Sanh Bui, Daniel James Blackman.   

Abstract

Distal protection devices have been proved to decrease distal embolization and improve outcome in unselected patients undergoing percutaneous coronary intervention (PCI) in saphenous vein grafts (SVGs). However, it remains uncertain whether distal protection is necessary in all patients. We investigated whether clinical or angiographic variables can predict distal embolization and, hence, need for a distal protection device. Fifty-eight consecutive SVGs that underwent PCI with a FilterWire distal protection device were studied. After the procedure, the FilterWire was fixed in formalin and photographed, and embolic debris area (square millimeters) was quantified by semi-automated edge-detection analysis. Debris area was correlated with 6 prespecified variables: clinical presentation, SVG age, reference lumen diameter, plaque volume, SVG degeneracy, and presence of a filling defect. Embolic debris was identified in 57 of 58 grafts (98%). Median debris area was 4.0 mm(2) (range 0.0 to 25.1). None of the prespecified variables predicted the occurrence of distal embolization or the amount of captured embolic debris. In conclusion, distal embolization during SVG PCI is universal. Embolic burden cannot be predicted by clinical or angiographic variables, and embolic protection should be used in all patients.

Entities:  

Mesh:

Year:  2007        PMID: 17317357     DOI: 10.1016/j.amjcard.2006.09.106

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Ubiquitous Nature of Distal Athero/Thromboembolic Events during Lower Extremity Atherectomy Procedures Involving the Superficial Femoral Artery.

Authors:  Najam Wasty; M Z Khakwani; Spas Kotev; Catalin Boiangiu; Omar Hasan; Manjusha Anna; Rajiv Tayal; Khalil Kaid; Gail Baker; Marc Cohen
Journal:  Int J Angiol       Date:  2016-09-05

2.  Early and midterm major adverse cardiac events in patient with saphenous vein graft using direct stenting or embolic protection device stenting.

Authors:  Mohammadali Sadr-Ameli; Hossein Mousavi; Mona Heidarali; Mohsen Maadani; Yones Ghelich; Behshid Ghadrdoost
Journal:  Res Cardiovasc Med       Date:  2014-02-24

3.  Dual antiplatelet agents and Rivaroxaban for massive intracoronary thrombus in STEMI.

Authors:  Nasiruddin Jamal; Mustaafa Bapumia
Journal:  Clin Case Rep       Date:  2015-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.